| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/05/2010 | US20100196438 Methods including medical devices having a surface including a biologically active agent therein |
| 08/05/2010 | US20100196437 Medical devices having a surface including a biologically active agent therein |
| 08/05/2010 | US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS |
| 08/05/2010 | US20100196410 Streptococcus pneumoniae Antigens and Vaccines |
| 08/05/2010 | US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof |
| 08/05/2010 | US20100196401 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 08/05/2010 | US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions |
| 08/05/2010 | US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo |
| 08/05/2010 | US20100196373 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy |
| 08/05/2010 | US20100196358 Method and kit to profile tumors by biomarker analyses including transcriptional factor assays |
| 08/05/2010 | US20100196339 Microparticle-Based Transfection and Activation of Dendritic Cells |
| 08/05/2010 | US20100196336 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
| 08/05/2010 | DE102009006606A1 Nicht-virales Transfektionsmittel Non-viral transfection |
| 08/05/2010 | CA2751268A1 Nucleic acid delivery using modified chitosans |
| 08/05/2010 | CA2751266A1 Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders |
| 08/05/2010 | CA2749325A1 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| 08/04/2010 | EP2214018A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 08/04/2010 | EP2213752A1 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 08/04/2010 | EP2213743A1 Albumin fusion proteins |
| 08/04/2010 | EP2213740A1 Human telomerase catalytic subunit |
| 08/04/2010 | EP2213738A2 siRNA molecules targeting Bcl-2 |
| 08/04/2010 | EP2213737A1 Double-stranded oligonucleotides |
| 08/04/2010 | EP2213736A2 Method for inhibiting the expression of a target gene and medicine for treating a tumour illness |
| 08/04/2010 | EP2213730A1 Primary cultured adipocytes for gene therapy |
| 08/04/2010 | EP2213309A1 Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent |
| 08/04/2010 | EP2213292A1 Double-stranded oligonucleotides |
| 08/04/2010 | EP2213291A1 Antisense inhibition of PTP1B expression |
| 08/04/2010 | EP2211871A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 08/04/2010 | CN1906302B Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 08/04/2010 | CN101796191A complexes of rna and cationic peptides for transfection and for immunostimulation |
| 08/04/2010 | CN101796184A Compositions and methods of treating cancer |
| 08/04/2010 | CN101795715A Stabilized immune modulatory RNA (SIMRA) compounds |
| 08/04/2010 | CN101795714A Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 08/04/2010 | CN101792765A Small RNA of human-mouse homologous Caspase-3 and application thereof |
| 08/04/2010 | CN101792763A Antisense oligonucleotide for specifically adjusting POKEMON gene expression and application thereof |
| 08/04/2010 | CN101792762A Antisense oligonucleotide for specifically adjusting POKEMON gene expression and application thereof |
| 08/04/2010 | CN101792744A Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792743A Recombinant baculovirus expressing porcine circovirus type 2 (PCV-2) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792742A Recombinant baculovirus expressing IBDV (Infectious Bursal Disease Virus) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792741A Recombinant baculovirus expressing Japanese Encephalitis Virus (JEV) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792740A Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof |
| 08/04/2010 | CN101792491A Recombinant adenovirus HIV vaccine based on multipleseries epi-position and preparation method thereof |
| 08/04/2010 | CN101791408A Cationic polymer gene vector having low cytotoxicity and high transfection efficiency, preparation method and use thereof |
| 08/04/2010 | CN101791397A Application of RNase III protein in staphylococcus aureus for preventing and treating staphylococcus aureus infection |
| 08/04/2010 | CN101269013B Method for preparing polymer microsphere |
| 08/03/2010 | US7767881 Mixture of histamine receptor protein and histamine receptor antagonist |
| 08/03/2010 | US7767790 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 08/03/2010 | US7767653 Enhancement of immune response to vaccine by interferon alpha |
| 08/03/2010 | US7767456 Non-viral gene delivery system |
| 08/03/2010 | US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename |
| 08/03/2010 | US7767405 Using glycosphingolipid GD2 specific immunoglobulin to treat cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 08/03/2010 | US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents |
| 08/03/2010 | US7767202 Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules |
| 08/03/2010 | US7767201 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same |
| 08/03/2010 | CA2265853C Inhibition of apoptosis using interleukin-1.beta.-converting enzyme (ice)/ced-3 family inhibitors |
| 08/03/2010 | CA2224777C New immunoregulatory protein lst-1 |
| 08/03/2010 | CA2190365C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 08/03/2010 | CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection |
| 07/29/2010 | WO2010084668A1 Diagnostic method for nephrotic syndrome, prophylactic or therapeutic agent for nephrotic syndrome, and method for screening the prophylactic or therapeutic agent |
| 07/29/2010 | WO2010084136A1 A dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma) |
| 07/29/2010 | WO2010084129A1 Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids |
| 07/29/2010 | WO2010060934A3 Cnnm proteins and uses thereof |
| 07/29/2010 | WO2010054266A3 Multiblock copolymers |
| 07/29/2010 | WO2010030963A3 Modulation of bcl11a for treatment of hemoglobinopathies |
| 07/29/2010 | US20100190964 Antibodies to human ErbB4 |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190243 siRNA-MEDIATED GENE SILENCING WITH VIRAL VECTORS |
| 07/29/2010 | US20100190176 Tumor suppressor designated ts10q23.3 |
| 07/29/2010 | US20100190169 Single nucleotide polymorphisms predicting cardiovascular disease |
| 07/29/2010 | US20100189743 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189736 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189735 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189734 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189733 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189732 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189708 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | US20100189684 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/29/2010 | US20100189680 Methods of Treating Various Cancers Using Melanoma Differentiating Associated Protein-7 |
| 07/28/2010 | EP2210956A2 Method to inhibit cell growth using oligonucleotides |
| 07/28/2010 | EP2210945A2 Neisseria meningitidis antigens |
| 07/28/2010 | EP2210617A1 Mammalian cells secreting Neurturin and their therapeutic use |
| 07/28/2010 | EP2209892A2 Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 07/28/2010 | EP2209495A1 Taz/wwtr1 for diagnosis and treatment of cancer |
| 07/28/2010 | EP1421199B1 Compositions for treating neurodegenerative diseases |
| 07/28/2010 | EP1315831B1 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 07/28/2010 | CN1927404B Application of siRNA inhibiting human Ezrin gene expression in esophagus cancer cell traveling invasion research |
| 07/28/2010 | CN101790310A Oncolytic vaccinia virus cancer therapy |
| 07/28/2010 | CN101787374A Recombinant adenovirus vector capable of specifically proliferating in tumor cells based on micro RNA regulation and control, and construction method and application thereof |
| 07/28/2010 | CN101787368A siRNA for restraining Z38 gene expression of human being and application thereof in preparing breast-tumor resisting medicine |
| 07/28/2010 | CN101787367A siRNA for restraining MAEL gene expression of human being and application thereof in preparing anti-tumor medicine |
| 07/28/2010 | CN101787366A DNA fragment for peculiarly inhibiting Rab27B gene expression and application thereof |
| 07/28/2010 | CN101787358A Tet-Off Advanced human stably expressing high-transition nasopharyngeal carcinoma cell line S18, construction method thereof and application thereof |
| 07/27/2010 | US7763722 Small interference RNA gene therapy |
| 07/27/2010 | US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 07/27/2010 | US7763711 Consisting of the amino acid sequence SVASTITGV, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases |
| 07/27/2010 | US7763592 SHIP-deficiency to increase megakaryocyte progenitor production |
| 07/27/2010 | US7763591 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage) |
| 07/27/2010 | US7763590 Nucleotide sequence complementary to wild-type gene; Rna strand which prevents gene expression |